Navigation Links
Statins Lower Risk of Clots in Cancer Patients
Date:10/27/2008

Study found those who took them were less likely to get venous thromboembolism

MONDAY, Oct. 27 (HealthDay News) -- A class of drugs widely used to lower cholesterol may have a future in preventing blood clots in patients with breast, lung, colon and other solid-organ cancers.

Research from scientists at the Albert Einstein Medical Center in Philadelphia found that cancer patients taking statins had a lower incidence of clots than did patients not taking the medications.

But experts cautioned that the results, which were expected to be presented at the American College of Chest Physicians' annual meeting in Philadelphia, are not yet ready for prime time.

Even the researchers noted the preliminary nature of the findings.

Study author Dr. Danai Khemasuwan called the discovery "thought-provoking," but added that randomized, controlled studies are needed before the results can be applied in the clinical arena.

Experts agreed with that analysis.

"This preliminary analysis is interesting, but far from confirmatory," said Dr. Carl "Chip" Lavie Jr., medical director of cardiac rehabilitation and prevention director of the stress testing laboratory at Ochsner Heart & Vascular Institute in New Orleans. "Statins could improve endothelial function, and this could reduce the chance of venous thrombosis. Conceivably, statins could have some benefits on clotting factors. It is known that statins can have platelet effects, but this should help arterial thrombosis and would not be expected to help venous thrombosis."

Venous thromboembolism (VTE) is a condition that includes deep vein thrombosis (DVT) as well as pulmonary embolism, or potentially fatal clots in the lung.

DVT is strongly linked to prolonged immobility, such as sitting in a plane for hours, but can strike anyone and, in fact, afflicts some 2 million Americans each year.

Statins are the class of drugs which include such well-known names as Zocor (simvastatin) and Lipitor (atorvastatin).

In addition to lowering cholesterol, researchers are looking into whether statins may lower the risk of certain types of cancer, as well as Alzheimer's.

The authors of this paper reviewed medical records for 740 patients admitted to the hospital with a diagnosis of breast, lung, colon, prostate, stomach, esophagus, pancreas, ovarian, kidney or brain cancer between October 2004 and September 2007.

Eight percent of patients who had been taking statins developed a VTE, compared with 21 percent in the control group (consisting of those individuals who had never used statins or who had only used them for less than two months).

The same results held true even after adjusting for smoking, metastatic disease, current chemotherapy, immobilization (a risk factor for DVT) and use of aspirin.

More information

The American Heart Association has more on deep vein thrombosis.



SOURCES: Carl "Chip" Lavie Jr., M.D., medical director, cardiac rehabilitation and prevention director, stress testing laboratory, Ochsner Heart & Vascular Institute, New Orleans; Danai Khemasuwan, M.D., Albert Einstein Medical Center, Philadelphia; Oct. 27, 2008, presentation, American College of Chest Physicians annual meeting, Philadelphia


'/>"/>
Copyright©2008 ScoutNews,LLC.
All rights reserved  

Related medicine news :

1. Stopping Statins After Stroke Doubles Death Risk
2. Research to shed new light on how statins benefit heart patients
3. Statins reduce loss of function, keeping old lungs young - even in smokers
4. Better Prostate Cancer Survival for Men Taking Statins
5. Statins After Bypass Lower Stroke Risk
6. Latest Study Says Statins Dont Slow Alzheimers
7. New Gene-Based Therapy an Alternative to Vytorin and Statins in Heart Disease Prevention and Treatment
8. Tendon complications, though rare, linked to statins
9. Cholesterol-Lowering Statins Tied to Tendon Woes
10. Women are treated less frequently than men with statins, aspirin and beta-blockers
11. iGuard.org Presents New Data on Statins at FDA Workshop Demonstrating How Patient-Reported Information Can Enhance Drug Safety Knowledge
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Statins Lower Risk of Clots in Cancer Patients
(Date:10/13/2017)... ... October 13, 2017 , ... The American Board of ... its next President and Chief Executive Officer, succeeding Dr. James C. Puffer upon his ... July 1, 2018 until Dr. Puffer’s retirement at the end of 2018. Upon assuming ...
(Date:10/13/2017)... ... 13, 2017 , ... PurhealthRX , a leading Health and Nutrition Company, ... Purzorb™process to full spectrum CBD oil will revolutionize the rapidly growing CBD market by ... be easily incorporated into liquid products, while reducing costs to end users. , The ...
(Date:10/13/2017)... ... ... Lori R. Somekh, founder of the Law Office of Somekh & Associates ... special needs planning attorneys. “Membership in ElderCounsel helps our office remain up to date ... elder law attorneys nationwide,” said Somekh. , ElderCounsel was founded by ...
(Date:10/13/2017)... ... 2017 , ... Many families have long-term insurance that covers care for a ... waiver for care if the client has a cognitive impairment diagnosis. , “What ... is often waived, so the benefits from their insurance start immediately,” said Mechell Vieira, ...
(Date:10/13/2017)... ... ... Ellevate Network, the leading network for professional women, brought together some of ... their inaugural Summit in New York City in June. The event was livestreamed with ... 3 million. To watch the Mobilize Women video, click here . , ...
Breaking Medicine News(10 mins):
(Date:10/2/2017)... 2017 Diplomat Pharmacy, Inc. (NYSE: ... Consulting, LLC , and named its founder as Diplomat,s ... Tennessee , will operate under Diplomat ... service offerings for health care partners to include IT ... "In an interoperable world, technology delivers comprehensive ...
(Date:10/2/2017)... ORLANDO, Fla. , Oct. 2, 2017  AllianceRx ... services company formed by Walgreens and pharmacy benefit manager ... of its new brand, which included the unveiling of ... Fla. , as well as at a few ... introduces the new brand to patients, some of whom ...
(Date:10/2/2017)... 2017 The Rebound mobile app is poised to ... the tide of prescription drug addiction. The app empowers users ... and stepping down their dosage in a safe, controlled manner ... 2017; the first 100,000 people to sign up will enjoy ... ...
Breaking Medicine Technology: